poisar

Stocks · News reference

Stifel Maintains Buy on Equinix, Raises Price Target to $1265

BenzingaJul 30, 2026, 5:03 PMBenzinga Newsdesk

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Jul 30, 2026, 5:03 PM
Checked
Jul 30, 2026, 5:02 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. The Motley FoolAug 26, 2026, 8:30 PMLeo Sun

    I'd Rather Own Bloom Energy Than Nvidia Right Now. Here's My Case.

    While both Bloom Energy and Nvidia are strong AI plays, analyst Leo Sun argues Bloom Energy offers better upside potential. Bloom develops solid oxide fuel cells for data center power, with a $20 billion backlog and backing from Brookfield Asset Management. Despite trading at 36x forward EBITDA versus Nvidia's 12x, Bloom's projected 70% revenue CAGR and 120% EBITDA CAGR (2025-2028) exceed Nvidia's 48% and 52% growth rates, while Nvidia faces increasing competition from AMD, Broadcom, and others.

    Read original at the-motley-fool
  2. The Motley FoolAug 26, 2026, 4:05 PMLeo Sun

    Will Bloom Energy Be the Next SpaceX? What the Numbers Actually Say.

    Bloom Energy's stock has surged 1,780% over two years, driven by strong demand from AI and cloud companies for its solid oxide fuel cells. With a $20 billion backlog and expected 70% revenue CAGR through 2028, the company is positioned as a leader in utility-scale fuel cell deployments. While trading at a premium valuation (71x adjusted EBITDA), analysts suggest it could outperform SpaceX as an investment due to its simpler business model and less competitive niche market.

    Read original at the-motley-fool
  3. The Motley FoolAug 14, 2026, 3:30 PMLeo Sun

    Bloom Energy vs. Oklo: Which AI-Power Stock Is the Smarter Buy Now?

    Bloom Energy and Oklo both target AI-driven energy demand through different technologies—Bloom with solid oxide fuel cells and Oklo with microreactors. Bloom has surged 2,030% over two years with established revenue and major customers, while Oklo has gained 510% but remains pre-revenue and speculative. Despite Bloom's strong valuation multiples, it remains the better buy compared to Oklo's overvalued 156x 2028 sales multiple.

    Read original at the-motley-fool